Susquehanna International Group’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-963
Closed -$3.56K 6690
2023
Q1
$3.56K Sell
963
-932
-49% -$3.45K ﹤0.01% 5813
2022
Q4
$7.21K Buy
+1,895
New +$7.21K ﹤0.01% 5516
2022
Q2
Sell
-917
Closed -$34K 6882
2022
Q1
$34K Sell
917
-760
-45% -$28.2K ﹤0.01% 5391
2021
Q4
$94K Sell
1,677
-1,510
-47% -$84.6K ﹤0.01% 5313
2021
Q3
$230K Buy
3,187
+1,190
+60% +$85.9K ﹤0.01% 4561
2021
Q2
$191K Sell
1,997
-1,339
-40% -$128K ﹤0.01% 4868
2021
Q1
$493K Buy
3,336
+1,347
+68% +$199K ﹤0.01% 3862
2020
Q4
$278K Buy
+1,989
New +$278K ﹤0.01% 3967
2018
Q3
Sell
-419
Closed -$33K 4936
2018
Q2
$33K Buy
419
+393
+1,512% +$31K ﹤0.01% 3459
2018
Q1
$2K Sell
26
-37
-59% -$2.85K ﹤0.01% 3289
2017
Q4
$47K Buy
+63
New +$47K ﹤0.01% 3441
2017
Q1
Sell
-147
Closed -$88K 4599
2016
Q4
$88K Sell
147
-55
-27% -$32.9K ﹤0.01% 3915
2016
Q3
$228K Buy
202
+7
+4% +$7.9K ﹤0.01% 2502
2016
Q2
$213K Sell
195
-311
-61% -$340K ﹤0.01% 2712
2016
Q1
$650K Buy
506
+253
+100% +$325K ﹤0.01% 2418
2015
Q4
$622K Sell
253
-293
-54% -$720K ﹤0.01% 2787
2015
Q3
$603K Buy
546
+364
+200% +$402K ﹤0.01% 2942
2015
Q2
$182K Buy
182
+19
+12% +$19K ﹤0.01% 4113
2015
Q1
$166K Buy
163
+54
+50% +$55K ﹤0.01% 3792
2014
Q4
$364K Buy
+109
New +$364K ﹤0.01% 3589
2014
Q3
Sell
-31
Closed -$117K 4342
2014
Q2
$117K Sell
31
-108
-78% -$408K ﹤0.01% 3998
2014
Q1
$759K Buy
+139
New +$759K ﹤0.01% 2309
2013
Q4
Sell
-27
Closed -$87K 4254
2013
Q3
$87K Buy
+27
New +$87K ﹤0.01% 3307